What novel therapies were discussed at ASH 2024?

A roundtable discussion on anemia management in myelodysplastic syndromes (MDS), Guillermo Garcia-Manero, MD, of the University of Texas MD Anderson Cancer Center; Amy DeZern, MD, MHS, of Johns Hopkins Medicine; Uma Borate, MBBS, of Ohio State University; and Tiffany Tanaka, MD, of the University of California San Diego, discuss the various options available to treat MDS patients who also have anemia, including luspatercept and imetelstat.
The roundtable also touches on other therapies, and how to design trials for novel therapies.

Watch the rest of this discussion now.